Idiopathic nephrotic syndrome is frequently diagnosed in childhood, and its unpredictable relapses can cause anxiety, depression, and reduced self-esteem in young patients.

From the articleRoche’s Gazyva secures FDA nod for idiopathic nephrotic syndrome, extending autoimmune pivot